Carroll Jill insider trades
Carroll Jill has filed 10 Form 4s with the SEC that we hold, for ACLX (Director) and Avalyn Pharma Inc. (AVLN) (Director). Across all of them we count 3 purchases worth $30.0M and 6 sales worth $103.3M reported on Form 4. In the last 12 months: 1 purchase ($5.0M) and 0 sales ($0). The largest single trade was a sale of 504,263 shares of ACLX worth $35.6M, dated 2024-03-21. The first filing on our record is dated 2022-02-09 and the latest 2026-05-01.
ACLX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-08 | P, purchase reported on Form 4 | 1,600,000 | $24.0M | 2022-02-09 |
| 2022-02-08 | P, purchase reported on Form 4 | 66,667 | $1.0M | 2022-02-09 |
| 2023-05-11 | S, sale reported on Form 4 | 631,932 | $28.4M | 2023-05-15 |
| 2023-05-11 | S, sale reported on Form 4 | 6,485 | $299.3K | 2023-05-15 |
| 2023-05-31 | S, sale reported on Form 4 | 315,164 | $13.1M | 2023-06-02 |
| 2023-06-01 | S, sale reported on Form 4 | 25,556 | $1.1M | 2023-06-02 |
| 2023-12-14 | S, sale reported on Form 4 | 504,263 | $24.8M | 2023-12-18 |
| 2024-03-21 | S, sale reported on Form 4 | 504,263 | $35.6M | 2024-03-25 |
Avalyn Pharma Inc. (AVLN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-01 | P, purchase reported on Form 4 | 277,778 | $5.0M | 2026-05-01 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1598542) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms